Detalhe da pesquisa
1.
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Genome Med
; 15(1): 16, 2023 03 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36915208
2.
DeepHCS++: Bright-field to fluorescence microscopy image conversion using multi-task learning with adversarial losses for label-free high-content screening.
Med Image Anal
; 70: 101995, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33640720
3.
High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma.
Cancers (Basel)
; 13(3)2021 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-33498427
4.
The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.
Cancers (Basel)
; 11(12)2019 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-31771104
5.
Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models.
Cancers (Basel)
; 11(8)2019 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31370279
6.
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.
Exp Mol Med
; 51(12): 1-11, 2019 12 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31811117
7.
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.
Genome Biol
; 20(1): 253, 2019 11 26.
Artigo
Inglês
| MEDLINE | ID: mdl-31771620
8.
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.
Cell Death Dis
; 9(8): 792, 2018 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-30022047
9.
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
Nat Genet
; 50(10): 1399-1411, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-30262818
10.
Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.
Exp Mol Med
; 52(11): 1869, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33149237